Method for Preparing Abiraterone Acetate
AssigneeWuhan Biocause Pharmaceutical Co., Ltd.
InventorsZhigang CHENG, Xuyong DAI, Xudong WANG, Shaokui LI, Liwei LI, Siyu HE, Sen CHENG
Life of this patent
Estimating the term…
Loading patent…
AssigneeWuhan Biocause Pharmaceutical Co., Ltd.
InventorsZhigang CHENG, Xuyong DAI, Xudong WANG, Shaokui LI, Liwei LI, Siyu HE, Sen CHENG
Estimating the term…
A method for preparing abiraterone acetate. The steps are: dehydroepiandrosterone acetate and trifluoromethanesulphonic anhydride undergo a sulfonylation reaction under the catalysis of an organic base to obtain a compound as represented by formula II; the compound is reacted with a 3-pyridine organoboron compound or a 3-pyridine organosilicone compound under the catalysis of Bis(triphenylphosphine) palladium(II) dichloride to obtain a crude abiraterone acetate product; the crude product is recrystallized in a protic or aprotic solvent to obtain an abiraterone acetate crystal; the crystal is further put into a solvent which easily dissolves the crystal and dissolved under heating, and the solution is dropwise added into a solvent which does not easily dissolve the crystal until a solid is precipitated under stirring, such that a micro powder abiraterone acetate is obtained; and the solvent which easily dissolves the crystal is a mixture of any two or more of acetone, ethanol and water, and the solvent which does not easily dissolve the crystal is water. The method has a rational route, a simple and convenient operation, a good product quality, and a high yield. No column chromatography, and salt-formation are required in the entire process to satisfy requirements of industrial scale productions. Furthermore, an abiraterone acetate particle size of about 10 um is obtained.
A method for preparing abiraterone acetate, comprises the following steps:
Dependencies are inferred from the claim text.